Wackenfors Angelica, Pantev Emil, Emilson Malin, Edvinsson Lars, Malmsjö Malin
Division of Experimental Vascular Research, Department of Internal Medicine, Lund University Hospital, SE-221 84 Lund, Sweden.
Basic Clin Pharmacol Toxicol. 2004 Dec;95(6):266-72. doi: 10.1111/j.1742-7843.2004.t01-1-pto950504.x.
Angiotensin II is a potent vasoconstrictor that is implicated in the pathogenesis of hypertension, heart failure and atherosclerosis. In the present study, angiotensin II receptor mRNA expression levels were quantified by real-time polymerase chain reaction and the vasocontractile responses to angiotensin II were characterised by in vitro pharmacology in endothelium-denuded human coronary arteries. Angiotensin II type 1 (AT(1)) and type 2 (AT(2)) receptor mRNA expression levels were significantly down-regulated in arteries from patients with heart failure as compared to controls. The angiotensin II-induced vasoconstriction diminished with increasing age in patients with heart failure (r(2)=0.31, P<0.05). Also, the AT(1) receptor mRNA expression levels decreased with increasing age in patients with heart failure (r(2)=0.74, P<0.05), while no such correlation could be shown in the control group (r(2)=0.04, P=n.s.). The AT(2) receptor mRNA expression levels did not correlate with age in patients with heart failure or controls. In conclusion, the diminished angiotensin II vasoconstriction with age in heart failure patients is most likely due to a lower density of AT(1) receptors and may result from a longer period of exposure to heart failure in older patients.
血管紧张素II是一种强效血管收缩剂,与高血压、心力衰竭和动脉粥样硬化的发病机制有关。在本研究中,通过实时聚合酶链反应对血管紧张素II受体mRNA表达水平进行定量,并通过体外药理学方法在内皮剥脱的人冠状动脉中表征对血管紧张素II的血管收缩反应。与对照组相比,心力衰竭患者动脉中血管紧张素II 1型(AT(1))和2型(AT(2))受体mRNA表达水平显著下调。心力衰竭患者中,血管紧张素II诱导的血管收缩随年龄增长而减弱(r(2)=0.31,P<0.05)。此外,心力衰竭患者中,AT(1)受体mRNA表达水平随年龄增长而降低(r(2)=0.74,P<0.05),而在对照组中未显示出这种相关性(r(2)=0.04,P=无显著性差异)。心力衰竭患者或对照组中,AT(2)受体mRNA表达水平与年龄均无相关性。总之,心力衰竭患者中血管紧张素II血管收缩随年龄增长而减弱很可能是由于AT(1)受体密度较低,可能是老年患者心力衰竭暴露时间较长所致。